Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report (2016)
Chapter: Appendix B: Committee Meeting 2 Agenda
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix A: Committee Meeting 1 Agenda
B
Next Chapter: Appendix C: Committee Biographies
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
B
Committee Meeting 2 Agenda
COMMITTEE ON A NATIONAL STRATEGY FOR THE ELIMINATION OF HEPATITIS B AND C
The Keck Center, 500 Fifth Street NW
Washington, DC 20001
December 16, 2015
Room 105
THE SCIENTIFIC AND CLINICAL FEASIBILITY OF ELIMINATING HCV
| 8:45-9:00 | Welcome and Introductions Brian Strom,Committee Chair |
| 9:00-9:30 | The Epidemiology and Natural History of Hepatitis C Virus David Thomas,Professor of Medicine and Director of Infectious Diseases, Johns Hopkins University School of Medicine |
| 9:30-10:00 | Screening and Clinical Management of Hepatitis C Marc Ghany,Staff Clinician, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health |
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
| 10:00-10:30 | Treatment of Hepatitis C Jay Hoofnagle,Director, Liver Disease Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health |
| 10:30-10:45 | Break |
| 10:45-11:15 | Prevalence of HCV and a Framework for Understanding Cost-Effectiveness Arthur Kim,Director Viral Hepatitis Clinic, Massachusetts General Hospital |
| 11:15-12:30 |
Panel Discussion on the Scientific and Clinical Feasibility of Eliminating HCV
|
THE LOGISTICAL AND SOCIAL FEASIBILITY OF ELIMINATING HCV
| 1:30-2:00 | Price and Access to Hepatitis C Drugs Camilla Graham,Assistant Professor of Medicine, Beth Israel Deaconess Medical Center |
| 2:00-2:30 | The National Infrastructure for Hepatitis C: Is There Anyone Home? Daniel O’Connell,Director, New York State Department of Health AIDS Institute |
| 2:30-2:45 | Break |
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
| 2:45-3:15 | The Feasibility of Eliminating Hepatitis C Among Injection Drug Users Brian Edlin,Senior Principal Investigator, Institute for Infectious Disease Research National Development and Research Institutes |
| 3:15-3:45 | The Logistics of Reaching the Hepatitis C Patient in Corrections Lara Strick,Infectious Disease Specialist, Washington State Department of Corrections (by video) |
| 3:45-5:00 |
Panel Discussion on the Logistical and Social Feasibility of Eliminating HCV Paul Kuehnert, Moderator
|
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
This page intentionally left blank.
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Suggested Citation:
"Appendix B: Committee Meeting 2 Agenda." National Academies of Sciences, Engineering, and Medicine. 2016. Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report. Washington, DC: The National Academies Press.
doi: 10.17226/23407.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.